JAAD-D-19-01125 Supplementary material

Published: 04-09-2019| Version 1 | DOI: 10.17632/zjhtfp7wwt.1
Contributor:
Omar Hasan Ali

Description

Supplemental table for publication JAAD-D-19-01125 (Hasan Ali O, et al. BP180-specific IgG is associated with skin adverse events, therapy response and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. J Am Acad Dermatol. 2019)

Files